Alphatec's second quarter revenue of $214M beat estimates as it raised its 2026 EBITDA outlook.

Alphatec reported second quarter 2026 revenue of $214 million, up 15% year-over-year, beating analyst expectations. The company posted a calculated non-GAAP EPS of $0.07, missing estimates. Management reaffirmed its full-year revenue guidance and raised its outlook for adjusted EBITDA, citing strong procedural volume.

Key Highlights

• Surgical revenue grew 17% year-over-year to $196 million, driven by a 20% increase in case volume.
• Adjusted EBITDA was $36 million, representing a margin of 16.8%, which is an expansion of 420 basis points from the prior year.
• The company raised its full-year 2026 adjusted EBITDA guidance to approximately $140 million from $134 million and reaffirmed its revenue outlook of approximately $882 million.
• ATEC generated positive free cash flow during the quarter, continuing its trend of trailing twelve-month free cash flow positivity.